North Randolph Dialysis Center Of Wake Forest University in High Point, North Carolina - Dialysis Center

North Randolph Dialysis Center Of Wake Forest University is a medicare approved dialysis facility center in High Point, North Carolina and it has 10 dialysis stations. It is located in Randolph county at 5948 Mendenhall Rd, High Point, NC, 27263. You can reach out to the office of North Randolph Dialysis Center Of Wake Forest University at (336) 434-8910. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. North Randolph Dialysis Center Of Wake Forest University has the following ownership type - Non-Profit. It was first certified by medicare in November, 2016. The medicare id for this facility is 342714 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameNorth Randolph Dialysis Center Of Wake Forest University
Location5948 Mendenhall Rd, High Point, North Carolina
No. of Dialysis Stations 10
Medicare ID342714
Managed ByIndependent
Ownership TypeNon-Profit
Late Shifts No

Contact Information


5948 Mendenhall Rd, High Point, North Carolina, 27263
(336) 434-8910
Not Available

Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with North Randolph Dialysis Center Of Wake Forest University from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1699129627
Organization NameNorth Randolph Dialysis Center
Doing Business AsNorth Randolph Dialysis Center Of Wake Forest University
Address5948 Mendenhall Road Ext Archdale, North Carolina, 27263
Phone Number(336) 434-8910

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data1

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center15
    Adult patient months included in Kt/V greater than or equal to 1.215
    Percentage of adult patients getting regular hemodialysis at the center100
    Percentage of pediatric patients getting regular hemodialysis at the center
  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center7
    Adult patient months included in Kt/V greater than or equal to 1.711
    Percentage of adult patients getting regular peritoneal dialysis at the center
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at North Randolph Dialysis Center Of Wake Forest University with elevated calcium levels.

Patients with hypercalcemia22
Hypercalcemia patient months26
Patients with Serumphosphor24
Patients with Serumphosphor less than 3.5 mg/dL11
Patients with Serumphosphor from 3.5 to 4.5 mg/dL21
Patients with Serumphosphor from 4.6 to 5.5 mg/dL43
Patients with Serumphosphor from 5.6 to 7 mg/dL14
Patients with Serumphosphor greater than 7 mg/dL11

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 8
Patient months included in arterial venous fistula and catheter summaries 15
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer